Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifshitz Law PLLC Announces Investigations of GeneDx Holdings Corp (NASDAQ: WGS), Helen of Troy Limited (NASDAQ: HELE), Calix, Inc. (NYSE: CALX), and Zoetis Inc. (NYSE: ZTS)

accessnewswire.com
WGS Investigation into possible securities law violations due to allegations of materially false and misleading statements regarding the importance of Fabric Genomics, its impact on margins, reimbursement rates, and overall business prospects. HELE Investigation into possible securities law violations due to allegations of overstating the success of Project Pegasus, downplaying implementation issues, and making misleading statements about cost-saving efficiencies and business prospects. CALX Investigation into possible securities law violations due to allegations of misleading statements about margins, benefiting from advanced memory component purchasing, and failing to disclose dwindling supply and negative margin pressure. ZTS Investigation into possible securities law violations due to allegations of misleading statements regarding weakening veterinarian prescription growth for Librela, market share loss for Simparica Trio and dermatology products, and overall business prospects.

NEW YORK CITY, NY / ACCESS Newswire / August 19, 2026 / Lifshitz Law Firm

GeneDx Holdings Corp (NASDAQ:WGS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company may have misled investors about the importance of Fabric Genomics; (ii) as a result, the Company's margins would suffer; (iii) the Company's average reimbursement rates were not as "durable" as previously disclosed; (iv) as a result of the foregoing, the Company's gross margins would decline; and (v) as a result of the foregoing, the Company's positive statements about GeneDx's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

If you are a WGS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Helen of Troy Limited (NASDAQ:HELE)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Helen of Troy overstated the success and benefits of its Project Pegasus initiative, touting the "fuel" it was generating while downplaying issues such as "implementation hiccups" at its Tennessee distribution center and assuring investors that the project was progressing and delivering cost-saving efficiencies; (ii) in reality, Project Pegasus was not delivering the efficiencies the Company claimed, as Helen of Troy lacked sufficient resources and budget to achieve its stated restructuring and cost-savings goals; and (iii) as a result, the Company's statements about Helen of Troy's business, operations, and prospects were materially false and misleading at all relevant times.

If you are an HELE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Calix, Inc. (NYSE:CALX)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's first quarter margins had significantly benefited from advanced purchasing of memory components; (ii) the Company's advanced supply of memory components was dwindling; (iii) as a result, the Company was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices; and (iv) as a result of the foregoing, the Company's positive statements about Calix's margins, business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a CALX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Zoetis Inc. (NYSE:ZTS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) veterinarian prescription growth and adoption of Zoetis' Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs; (ii) Zoetis' Simparica Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; (iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment; and (iv) as a result of the foregoing, the Company's positive statements about Zoetis' business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you are a ZTS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE: Lifshitz Law Firm